Paul M.

Paul M. serves as the Executive Chairman of Island Pharmaceuticals since January 2020, focusing on drug repurposing for new antiviral therapies. Additionally, Paul M. holds the position of Chairman at AdAlta Ltd, addressing novel antibodies for fibrotic diseases, and has been a Non-Executive Director at GreyScan Australia Pty Ltd since November 2021, specializing in detection technologies. As a member of the Advisory Panel for Mind Medicine Australia and the International Advisory Board for PharmaVentures, Paul M. contributes expertise in the pharmaceutical sector. Paul M. has past leadership experience as Chairman of the Australian Industry Skills Committee's Pharmaceutical Industry Reference Committee and in advisory roles for companies like Upkara and SuperTrans Medical Ltd. Educational qualifications include a Master of Business Administration from Macquarie Graduate School of Management and a Bachelor of Veterinary Science from the University of Sydney, among other degrees.